Chapter
Healthcare Reform: Right to Try Laws and Regulatory Burdens
1:11:57 - 1:16:46 (04:49)
The possibility of the federalization of right to try laws may bring about a big shift in healthcare policy, allowing doctors and patients to try drugs at their own discretion without federal oversight. However, one of the major existing problems in the healthcare system is the high regulatory burden on healthcare, pharmaceutical, and testing companies.
Clips
The COVID-19 pandemic has highlighted the gaps in the healthcare system that need to be addressed.
1:11:57 - 1:13:47 (01:50)
Summary
The COVID-19 pandemic has highlighted the gaps in the healthcare system that need to be addressed. The crisis provides an opportunity for a positive recalibration of healthcare industry focusing on ethics, morality and personal values.
ChapterHealthcare Reform: Right to Try Laws and Regulatory Burdens
EpisodeE1: US Response to COVID-19 & Impact on Startups, Venture Capital & Public Markets with David Friedberg
PodcastAll-In with Chamath, Jason, Sacks & Friedberg
This episode discusses the high regulatory burden on healthcare companies, and how right to try laws may be federalized to allow patients and doctors to have more discretion in trying new drugs.
1:13:46 - 1:16:46 (02:59)
Summary
This episode discusses the high regulatory burden on healthcare companies, and how right to try laws may be federalized to allow patients and doctors to have more discretion in trying new drugs. It is suggested that removing regulatory burdens could help make healthcare more affordable and increase efficiency.